Literature DB >> 12181038

Chromatin modification, leukaemia and implications for therapy.

Louise K Jones1, Vaskar Saha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12181038     DOI： 10.1046/j.1365-2141.2002.03586.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study.

Authors:  Enrique M Ocio; Pilar Herrera; María-Teresa Olave; Nerea Castro; José A Pérez-Simón; Salut Brunet; Albert Oriol; Marta Mateo; Miguel-Ángel Sanz; Javier López; Pau Montesinos; María-Carmen Chillón; María-Isabel Prieto-Conde; María Díez-Campelo; Marcos González; María-Belén Vidriales; María-Victoria Mateos; Jesús F San Miguel
Journal:  Haematologica       Date:  2015-07-09       Impact factor: 9.941

Review 2.  Epigenetic aberrations during oncogenesis.

Authors:  Maria Hatziapostolou; Dimitrios Iliopoulos
Journal:  Cell Mol Life Sci       Date:  2011-01-20       Impact factor: 9.261

3.  Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.

Authors:  Carine Robert; Pratik K Nagaria; Nisha Pawar; Adeoluwa Adewuyi; Ivana Gojo; David J Meyers; Philip A Cole; Feyruz V Rassool
Journal:  Leuk Res       Date:  2016-03-30       Impact factor: 3.156

Review 4.  Novel therapeutic agents for cutaneous T-Cell lymphoma.

Authors:  Salvia Jain; Jasmine Zain; Owen O'Connor
Journal:  J Hematol Oncol       Date:  2012-05-17       Impact factor: 17.388

Review 5.  Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?

Authors:  Sebastian Stintzing; Ralf Kemmerling; Tobias Kiesslich; Beate Alinger; Matthias Ocker; Daniel Neureiter
Journal:  J Biomed Biotechnol       Date:  2011-05-15

6.  The DAC system and associations with acute leukemias and myelodysplastic syndromes.

Authors:  Gesine Bug; Oliver G Ottmann
Journal:  Invest New Drugs       Date:  2010-12-14       Impact factor: 3.850

Review 7.  Linking the epigenetic 'language' of covalent histone modifications to cancer.

Authors:  S B Hake; A Xiao; C D Allis
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

Review 8.  Acetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets.

Authors:  Nasir Javaid; Sangdun Choi
Journal:  Genes (Basel)       Date:  2017-08-07       Impact factor: 4.096

9.  Expression and Regulation Network of HDAC3 in Acute Myeloid Leukemia and the Implication for Targeted Therapy Based on Multidataset Data Mining.

Authors:  Minhua Li; Feifei Lan; Chen Li; Ning Li; Xiaojie Chen; Yueyuan Zhong; Yue Yang; Yingqi Shao; Yi Kong; Xinming Li; Danny Wu; Jingyu Zhang; Wenqing Chen; Zesong Li; Xiao Zhu
Journal:  Comput Math Methods Med       Date:  2022-03-14       Impact factor: 2.809

10.  [Research Progress of Epigenetics in Pathogenesis and Treatment of Malignant Tumors].

Authors:  Pan Wang; Honglin Zhao; Fan Ren; Qingchun Zhao; Ruifeng Shi; Xingyu Liu; Jinghao Liu; Yongwen Li; Ying Li; Hongyu Liu; Jun Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-02-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.